diaziquone has been researched along with Nausea in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bramwell, V; Dombernowsky, P; Hansen, HH; Lund, B; Renard, J | 1 |
| Creagan, ET; Edmonson, JH; Kvols, LK; Long, HJ; O'Fallon, JR | 1 |
| Baker, LH; Balcerzak, SP; Rivkin, SE; Stephens, RL; Zidar, BL | 1 |
3 other study(ies) available for diaziquone and Nausea
| Article | Year |
|---|---|
Phase II trial of diaziquone in advanced ovarian carcinoma. European Organization for Research on Treatment of Cancer Early Clinical Trials Group.
Topics: Adult; Aged; Aziridines; Azirines; Benzoquinones; Cystadenocarcinoma; Drug Evaluation; Female; Gastrointestinal Hemorrhage; Humans; Leukopenia; Middle Aged; Nausea; Neoplasm Metastasis; Ovarian Neoplasms; Vomiting | 1985 |
Phase II trial of diaziquone in advanced upper aerodigestive cancer.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Leukocyte Count; Male; Middle Aged; Mouth Neoplasms; Nausea; Otorhinolaryngologic Neoplasms; Platelet Count | 1985 |
Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.
Topics: Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Bone Neoplasms; Drug Evaluation; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Sarcoma; Soft Tissue Neoplasms | 1985 |